Profile
Dr. Gregory S.
Wagner is Senior Vice President-Research & Development at Resverlogix Corp.
Dr. Wagner was previously employed as Vice President-PreClinical Development by Galileo Pharmaceuticals, Inc.
He received his undergraduate degree from the University of Illinois, a graduate degree from the University of Iowa, and a doctorate degree from the University of Iowa.
Former positions of Gregory S. Wagner
| Companies | Position | End |
|---|---|---|
Galileo Pharmaceuticals, Inc.
 Galileo Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Galileo Pharmaceuticals, Inc. develops therapeutics and pharmaceuticals for redox failure such as stroke, heart attack, and diabetes. It also owns and operates laboratories. The company was founded by Dr. Guy Miller in 1998 and is headquartered in Santa Clara, CA. | Corporate Officer/Principal | 2005-12-31 |
| RESVERLOGIX CORP. | Corporate Officer/Principal | - |
Training of Gregory S. Wagner
| University of Iowa | Doctorate Degree |
| University of Illinois | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| RESVERLOGIX CORP. | Health Technology |
| Private companies | 1 |
|---|---|
Galileo Pharmaceuticals, Inc.
Galileo Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Galileo Pharmaceuticals, Inc. develops therapeutics and pharmaceuticals for redox failure such as stroke, heart attack, and diabetes. It also owns and operates laboratories. The company was founded by Dr. Guy Miller in 1998 and is headquartered in Santa Clara, CA. | Health Technology |
- Stock Market
- Insiders
- Gregory S. Wagner
